Wnt/β-catenin signaling restrains developmental beiging and imprints long-term energy expenditure

This study reveals that canonical Wnt/β-catenin signaling acts as a developmental brake on beige adipocyte formation, and its suppression during the peri-weaning period activates a Wnt5a-Ca2+-AMPK axis to drive SNS-independent thermogenesis and sustain long-term energy expenditure.

The Gist

The Big Picture: Turning "White" Fat into "Brown" Fat

Imagine your body has two types of fat:

1. White Fat: This is the "storage warehouse." It's like a giant, quiet warehouse where you keep extra energy (calories) for a rainy day. It doesn't do much else.
2. Brown/Beige Fat: This is the "furnace." It burns energy to create heat. It's like a high-performance engine that keeps you warm and burns off excess fuel.

As we get older, our bodies tend to build more "warehouses" (white fat) and fewer "furnaces" (brown fat). This makes it harder to stay thin and healthy. Scientists have been trying to figure out how to turn those warehouses back into furnaces to help fight obesity and diabetes.

The Discovery: A "Brake" on the Furnace

This study discovered a specific biological "brake" that stops our bodies from building these furnaces naturally.

• The Brake: A signaling pathway called Wnt/β-catenin. Think of this as a heavy, rusty lock on the door of the furnace room. In adults, this lock is tight, preventing the fat cells from turning into energy-burning furnaces.
• The Key: The researchers found that if you remove this lock (by inhibiting the Wnt signal), the fat cells spontaneously transform into "beige" fat cells (a hybrid furnace) that burn energy.

The "Golden Window": Why Babies Are Different

The researchers noticed something interesting about baby mice (during the "peri-weaning" period, right after they stop nursing).

• The Natural State: During this specific time, the "rusty lock" (Wnt signaling) naturally loosens up. Because the lock is loose, baby mice naturally build a lot of beige fat furnaces, even without being cold.
• The Problem: As the mice grow up, the lock gets tightened again, and those furnaces go dormant (they turn back into storage warehouses).

The Breakthrough: The team genetically engineered mice to keep that "lock" open permanently.

• The Result: These mice didn't just have more furnaces as babies; they kept them into adulthood. Even when they were fully grown, their fat cells kept burning energy.
• The Outcome: These mice stayed thinner, had higher energy expenditure (they burned more calories just sitting there), and had better metabolic health, all without needing to exercise or eat less.

How It Works: The "Fuel Switch"

The paper explains how this happens inside the cell using a clever analogy:

1. The Conflict: Inside the cell, there are two competing teams.
   • Team A (The Brake): The Wnt/β-catenin team. They say, "Store the fuel! Don't burn it!"
   • Team B (The Accelerator): The Wnt5a-Ca2+-AMPK team. They say, "Burn the fuel! Make heat!"
2. The Switch: Normally, Team A is the boss. They suppress Team B.
3. The Change: When the researchers removed the "Brake" (Team A), Team B took over.
   • Team B triggers a chain reaction: It releases calcium, which wakes up an enzyme called AMPK.
   • AMPK acts like a fuel pump. It breaks down fat droplets (triglycerides) and sends them straight to the mitochondria (the cell's power plant) to be burned for heat.

Crucial Finding: The researchers found that you can't just turn on Team B (by adding Wnt5a) if Team A is still in charge. The "Brake" must be released first. Once the brake is off, the fuel pump turns on automatically.

Does This Work in Humans?

Yes! The researchers tested this on human fat cells taken from liposuction patients.

• When they applied a drug to block the "Brake" (Wnt/β-catenin) in human fat cells, those cells also started acting like furnaces. They got smaller, burned more fat, and produced heat.
• This suggests that the same mechanism exists in humans, opening the door for potential new weight-loss or diabetes treatments that don't rely on the nervous system (which is often how current "fat-burning" drugs work).

Why This Matters

Most current strategies to burn fat rely on the Sympathetic Nervous System (the "fight or flight" system). Think of this like revving a car engine by pressing the gas pedal hard. It works, but it's stressful for the body (raising heart rate and blood pressure) and the effect doesn't last long.

This study offers a new route:

• Instead of pressing the gas pedal (nervous system), they found a way to remove the parking brake (Wnt signaling).
• This allows the body to burn energy independently of stress or cold.
• It creates a "set point" where the body naturally burns more calories, potentially offering a sustainable way to improve metabolic health and fight obesity.

Summary Analogy

Imagine your body's fat cells are a house with a thermostat.

• Normal Adults: The thermostat is set to "Eco Mode" (save energy, store fat). The Wnt signal is the lock keeping the thermostat stuck there.
• The Study: The scientists found the key to unlock the thermostat. Once unlocked, the house automatically switches to "Heating Mode" (burning fat).
• The Magic: Even better, once you unlock it in the "construction phase" (childhood), the house remembers this setting forever. It stays in "Heating Mode" even when you grow up, keeping you warm and thin without you having to do anything extra.

Technical Summary

1. Problem Statement

• Context: Thermogenic beige adipocytes improve metabolic health by dissipating energy as heat. In adult mammals, beige adipocyte recruitment is primarily driven by the sympathetic nervous system (SNS) via $\beta$-adrenergic signaling. However, this reliance limits the durability of therapeutic strategies, and pharmacological $\beta$-adrenergic agonists carry cardiovascular risks.
• Gap: While spontaneous beige adipocyte biogenesis occurs during the peri-weaning period in mice independently of cold exposure or SNS input, the molecular mechanisms governing this developmental window are poorly understood. Specifically, the endogenous signals that act as "brakes" or "accelerators" on this spontaneous beiging process remain unclear.
• Objective: To identify the intrinsic molecular signals regulating developmental beige thermogenesis and determine if modulating these signals can sustainably enhance energy expenditure independent of SNS activation.

2. Methodology

The study employed a multi-faceted approach combining in vivo genetics, in vitro pharmacology, and transcriptomics:

• Animal Models:
  • Adipocyte-specific $Ctnnb1$ knockout: Generated using Adipoq-Cre crossed with Ctnnb1$^{flox/flox}$ mice to delete $\beta$-catenin specifically in mature adipocytes.
  • Transcription-specific mutant: Used Adipoq-Cre; Ctnnb1$^{dm/flox}$ mice, where $\beta$-catenin retains structural function but lacks transcriptional activity, to distinguish between signaling and structural roles.
  • Lineage-specific knockout: Ucp1-Cre; Ctnnb1$^{flox/flox}$ mice to target deletion specifically in Ucp1-expressing beige adipocytes.
  • Controls: Littermate controls and wild-type mice at various ages (3–8 weeks).
• Tissue Analysis:
  • Depots: Inguinal white adipose tissue (iWAT, subcutaneous), brown adipose tissue (BAT), and epididymal white adipose tissue (eWAT).
  • Timepoints: Peri-weaning (4 weeks) vs. Adulthood (8 weeks).
  • Spatial Analysis: Compared anterior, middle, and posterior regions of iWAT.
• In Vitro Models:
  • Mouse: Stromal vascular fraction (SVF) cells from iWAT differentiated into adipocytes.
  • Human: Primary subcutaneous adipocytes from liposuction aspirates.
  • Pharmacological Manipulation:
    • MSAB: $\beta$-catenin destabilizer (inhibits canonical Wnt).
    • BAPTA-AM: Intracellular $Ca^{2+}$ chelator.
    • Box5: Selective antagonist of Wnt5a/$Ca^{2+}$ signaling.
    • Recombinant Wnt5a: To test ligand sufficiency.
    • Rosiglitazone: Positive control for beiging.
• Assays:
  • Omics: Bulk RNA-seq (tissue and differentiated adipocytes) and KEGG pathway enrichment.
  • Molecular: qPCR, Western blotting (signaling pathways, thermogenic markers), Immunofluorescence.
  • Functional: Seahorse XF Analyzer for mitochondrial respiration (OCR), metabolic cages for whole-body energy expenditure (EE), and H&E staining for morphology.

3. Key Contributions & Findings

A. Wnt/$\beta$-catenin as a Developmental Brake

• Observation: In wild-type mice, canonical Wnt signaling (measured by Axin2, Lef1, $\beta$-catenin protein) is naturally low during the peri-weaning period (4 weeks) when spontaneous beiging peaks, and high in adulthood (8 weeks) when beiging declines.
• Genetic Validation: Adipocyte-specific deletion of Ctnnb1 ($\beta$-catenin) in 4-week-old mice resulted in:
  • Smaller, multilocular adipocytes in iWAT (beige morphology).
  • Upregulation of thermogenic genes (Ucp1, Cpt1b) and proteins (UCP1, OXPHOS).
  • Increased mitochondrial respiratory capacity.
  • Specificity: This effect was restricted to subcutaneous iWAT; BAT and visceral eWAT were unaffected.
• Mechanism: The phenotype was driven by the loss of transcriptional Wnt signaling, not structural cell adhesion functions (confirmed by the Ctnnb1$^{dm}$ mutant model).

B. Long-Term Metabolic Imprinting

• Persistence: The enhanced thermogenic phenotype in Adipoq-Cre; Ctnnb1$^{flox/flox}$ mice persisted into adulthood (8 weeks) despite the return of normal Wnt signaling levels in wild-types.
• Systemic Impact: Adult knockout mice exhibited:
  • Reduced body weight and fat mass.
  • Sustained increase in whole-body energy expenditure (EE) and oxygen consumption.
  • No significant changes in food intake or respiratory exchange ratio (RER).
  • Normal adipogenic differentiation and endocrine function (adiponectin levels unchanged), indicating the effect is specific to thermogenic programming rather than a general defect in adipogenesis.

C. The Non-Canonical Wnt5a-$Ca^{2+}$-AMPK Axis

• Mechanistic Discovery: RNA-seq and Western blotting revealed that $\beta$-catenin deletion activates a non-canonical Wnt pathway:
  1. Upregulation: Increased expression of ligand Wnt5a and receptor Fzd5.
  2. Signaling Cascade: Enhanced phosphorylation of CaMKK2 and AMPK.
  3. Downstream Effectors: Activation of Sirt1, Pgc1$\alpha$, and PPAR$\gamma$/$\alpha$, leading to increased triglyceride lipolysis (Atgl) and fatty acid oxidation.
• Causality:
  • $Ca^{2+}$ Dependence: Chelating intracellular calcium (BAPTA-AM) abolished the thermogenic effects of MSAB (Wnt inhibitor).
  • Wnt5a Requirement: Blocking Wnt5a signaling (Box5) blunted the beiging response to $\beta$-catenin inhibition.
  • Hierarchy: Exogenous Wnt5a failed to induce beiging if canonical Wnt/$\beta$-catenin signaling was intact. Thus, relief of the canonical Wnt brake is a prerequisite for the non-canonical Wnt5a-$Ca^{2+}$-AMPK axis to drive thermogenesis.

D. Conservation in Humans

• Pharmacological inhibition of Wnt/$\beta$-catenin in human subcutaneous adipocytes (using MSAB) recapitulated the mouse phenotype:
  • Reduced lipid droplet size and multilocular morphology.
  • Upregulation of WNT5A, p-CAMKK2, p-AMPK, SIRT1, PGC1$\alpha$, and UCP1.
  • This confirms the mechanism is evolutionarily conserved and not limited to murine models.

4. Significance

• Novel Mechanism: Identifies canonical Wnt/$\beta$-catenin signaling as a previously unknown developmental constraint on beige adipocyte formation.
• SNS-Independent Pathway: Demonstrates a route to activate thermogenesis that does not rely on the sympathetic nervous system, bypassing the limitations and risks of $\beta$-adrenergic therapies.
• Developmental Programming: Suggests that modulating Wnt signaling during the peri-weaning window can "imprint" a higher thermogenic set point that persists into adulthood, offering a potential window for early-life metabolic intervention.
• Therapeutic Potential: The discovery of the Wnt5a-$Ca^{2+}$-AMPK axis as a downstream effector provides new drug targets for treating obesity and metabolic disorders by enhancing energy expenditure through lipid mobilization and mitochondrial uncoupling.

Conclusion

The study establishes that Wnt/$\beta$-catenin signaling acts as a physiological brake on spontaneous beige adipogenesis. Its inhibition during development releases a non-canonical Wnt5a-$Ca^{2+}$-AMPK axis, driving lipid oxidation and mitochondrial thermogenesis. This mechanism is conserved in humans and offers a promising, SNS-independent strategy to sustainably increase energy expenditure and improve metabolic health.